These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 23523101)
1. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress. Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101 [TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis. Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026 [TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling. Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007 [TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis. Xue X; Li Y; Zhang S; Yao Y; Peng C; Li Y Phytomedicine; 2024 Sep; 132():155830. PubMed ID: 38959553 [TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation. Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212 [TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro. Li CC; Yang CZ; Li XM; Zhao XM; Zou Y; Fan L; Zhou L; Liu JC; Niu YC Eur J Pharm Sci; 2012 Aug; 46(5):397-404. PubMed ID: 22449726 [TBL] [Abstract][Full Text] [Related]
7. Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats. He Y; Liu Q; Li Y; Yang X; Wang W; Li T; Zhang W; Cui Y; Wang C; Lin R J Physiol Biochem; 2015 Mar; 71(1):69-78. PubMed ID: 25626885 [TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling. Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065 [TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro. Pan R; Zhang Y; Zang B; Tan L; Jin M J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091 [TBL] [Abstract][Full Text] [Related]
10. Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride. Li Y; Shi Y; Sun Y; Liu L; Bai X; Wang D; Li H Mol Med Rep; 2017 Jan; 15(1):47-56. PubMed ID: 27909717 [TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A. Wang C; Huang Q; Wang C; Zhu X; Duan Y; Yuan S; Bai X Toxicol Appl Pharmacol; 2013 Nov; 272(3):895-904. PubMed ID: 23933165 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats. Jin M; Wang L; Wu Y; Zang BX; Tan L Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256 [TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action. Tian J; Li G; Liu Z; Fu F Pharmacology; 2008; 82(2):121-6. PubMed ID: 18583922 [TBL] [Abstract][Full Text] [Related]
14. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Cheng Y; Ping J; Xu LM Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121 [TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice. Jin M; Wu Y; Wang L; Zang B; Tan L Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519 [TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS]. Wu W; Jin M; Tong J; Wang XF; Zang BX Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies. Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724 [TBL] [Abstract][Full Text] [Related]
18. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways. Zhang F; Ni C; Kong D; Zhang X; Zhu X; Chen L; Lu Y; Zheng S Toxicol Appl Pharmacol; 2012 Nov; 265(1):51-60. PubMed ID: 23022513 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling. Song Y; Long L; Zhang N; Liu Y Mol Med Rep; 2014 Sep; 10(3):1555-60. PubMed ID: 24939805 [TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway. Su D; Lv C Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]